Insider Trading

Recent SEC filings have revealed a significant development for biotechnology firm Design Therapeutics: investment management company Acadian Asset Management now...

Shares of space technology company Redwire faced intense selling pressure following news that a major institutional investor is significantly reducing...

A stark divergence has emerged at Energy Vault Holdings, Inc., where robust insider buying by the chief executive contrasts sharply...

While Nautilus Biotechnology's stock has faced substantial selling pressure for months, a significant development has emerged from the executive suite....

A notable divergence has emerged at Recursion Pharmaceuticals between the actions of corporate insiders and the outlook of Wall Street...

Guidewire Software finds itself at a fascinating crossroads. The company is making a bold $60 million strategic investment to capture...

A significant series of stock disposals by key executives at solid-state battery developer QuantumScape has unsettled the investment community, casting...

Recent insider trading activity at Group 1 Automotive is prompting investor scrutiny, raising questions about whether company executives believe the...

Tesla's stock has broken out of its prolonged slump, propelled by two powerful catalysts: a massive personal investment by CEO...

The investment narrative surrounding Crinetics Pharmaceuticals presents a complex puzzle for market participants. On one hand, institutional money is flowing...